7 results match your criteria: "Muljibhai Patel Urological Hospital Nadiad[Affiliation]"
Am J Clin Exp Urol
August 2023
Department of Pathology, Molecular Biology and Transplant Immunology, Muljibhai Patel Urological Hospital Nadiad-387001, Gujarat, India.
Tacrolimus is an immunosuppressant with a narrow therapeutic index and pharmacokinetic variability. This variability may be attributed to genetic variants in gene associated with Tacrolimus metabolism. Studies focusing on genetic variants in the gene associated with Tacrolimus metabolism have been published, a meta-analysis of these published articles may provide a direction that can change the future research and clinical management of renal transplant patients.
View Article and Find Full Text PDFAm J Clin Exp Urol
April 2023
Department of Urology, Muljibhai Patel Urological Hospital Nadiad, India.
Background: RAKT is a relatively newer approach for kidney transplant and has to be proven against the established approach, OKT. RAKT may be beneficial in obese patients as described in literature. Hence, we compared pre-, intra- and postoperative parameters with one year follow-up of both approaches by propensity matching similar characteristics patients.
View Article and Find Full Text PDFJ Vasc Access
July 2024
Department of Biostatistics, Muljibhai Patel Urological Hospital Nadiad, India.
Background: Catheter-Related Blood Stream Infection (CRBSI) is the major limitation of using Tunneled cuffed catheter (TCC) for long-term Hemodialysis. The standard therapy of CRBSI involves systemic antibiotics with catheter replacement/removal. As antibiotic alone is rarely effective therapy for CRBSI, biofilm eradication using antimicrobial locking solutions is a promising modality for CRBSI treatment, hence catheter salvage.
View Article and Find Full Text PDFAm J Clin Exp Urol
June 2021
Department of Urology, Muljibhai Patel Urological Hospital Nadiad, Gujarat, India.
Objective: The aim of the present study was to develop a nomogram to accurately predict the need for intervention in patients suffering from LUTS due to benign prostatic hyperplasia (BPH) and internally validate it.
Material And Methods: The data was collected from the community subjects from the state of Gujarat in western India. All the demographic data, physical examination, PSA, uroflowmetry and prostatic ultrasound was collected in 92 subjects and were followed up after 2 years.
J Endourol
October 2004
Department of Urology, Muljibhai Patel Urological Hospital Nadiad, Gujarat, India.
Background And Purpose: Bleeding is a major concern during percutaneous nephrolithotomy (PCNL), especially with the use of multiple tracts. This prospective study aimed to identify factors affecting blood loss during PCNL.
Patients And Methods: Data were collected prospectively from 236 patients undergoing 301 PCNL procedures at our institute since June 2002.